bullish
SillaJen IPO Part 3 - Competitive Strengths of Product (Pexa-Vec)
260 Views21 Nov 2016 13:33
* In Part 3 (as below), I summarized the competitive strengths of product (Pexa-Vec).SillaJen's Pexa-Vec is an advanced liver cancer treatment...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- SillaJen - Pipeline Review & Valuation Study25 Oct 2017
- SillaJen IPO Part 5 - Revenue & Valuation Estimates with Pexa-Vec's First Commercialization Year29 Nov 2016
- SillaJen IPO Part 4 - IPO Price & Post-IPO Risks26 Nov 2016
- SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level03 Nov 2016
- SillaJen IPO Part 1 - Schedule, Financials & Valuation02 Nov 2016
x